Sarcosine attenuates toluene-induced motor incoordination, memory impairment, and hypothermia but not brain stimulation reward enhancement in mice

Toxicology and Applied Pharmacology

Volumn 265, Issue 2, 2012, Pages 158-165

  Chan, Ming Huan ^a,d   Chung, Shiang Sheng ^a,b   Stoker, Astrid K ^c   Markou, Athina ^c   Chen, Hwei Hsien ^a,e  

^a TZU CHI UNIVERSITY   (Taiwan)

^b YULI VETERANS HOSPITAL   (Taiwan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NATIONAL CHENGCHI UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Body temperature; Intracranial self stimulation; Motor coordination; Recognition memory; Toluene

Indexed keywords

SARCOSINE; TOLUENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BRAIN DEPTH STIMULATION; CONTROLLED STUDY; COORDINATION DISORDER; DOSE RESPONSE; DRUG EFFECT; HYPOTHERMIA; MALE; MEMORY DISORDER; MOUSE; NONHUMAN; RECOGNITION; RECTUM TEMPERATURE; ROTAROD TEST;

ANIMALS; ATAXIA; BODY TEMPERATURE; BRAIN; DRUG INTERACTIONS; HYPOTHERMIA; MALE; MEMORY DISORDERS; MICE; RECEPTORS, N-METHYL-D-ASPARTATE; SARCOSINE; SELF STIMULATION; TOLUENE;

MUS;

EID: 84868507766     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2012.10.004     Document Type: Article

References (50)

1. Andersen I., Lundqvist G.R., Molhave L., Pedersen O.F., Proctor D.F., Vaeth M., Wyon D.P. Human response to controlled levels of toluene in six-hour exposures. Scand. J. Work Environ. Health 1983, 9:405-418.
2. Anderson C.E., Loomis G.A. Recognition and prevention of inhalant abuse. Am. Fam. Physician 2003, 68:869-874.
3. Bespalov A., Sukhotina I., Medvedev I., Malyshkin A., Belozertseva I., Balster R., Zvartau E. Facilitation of electrical brain self-stimulation behavior by abused solvents. Pharmacol. Biochem. Behav. 2003, 75:199-208.
4. Bowen S.E., Balster R.L. A direct comparison of inhalant effects on locomotor activity and schedule-controlled behavior in mice. Exp. Clin. Psychopharmacol. 1998, 6:235-247.
5. Bowen S.E., Wiley J.L., Jones H.E., Balster R.L. Phencyclidine- and diazepam-like discriminative stimulus effects of inhalants in mice. Exp. Clin. Psychopharmacol. 1999, 7:28-37.
6. Bowen S.E., Kimar S., Irtenkauf S. Comparison of toluene-induced locomotor activity in four mouse strains. Pharmacol. Biochem. Behav. 2010, 95:249-257.
7. Bushnell P.J., Evans H.L., Palmes E.D. Effects of toluene inhalation on carbon dioxide production and locomotor activity in mice. Fundam. Appl. Toxicol. 1985, 5:971-977.
8. Carlezon W.A., Wise R.A. Phencyclidine-induced potentiation of brain stimulation reward: acute effects are not altered by repeated administration. Psychopharmacology 1993, 111:402-408.
9. Chan M.H., Chien T.H., Lee P.Y., Chen H.H. Involvement of NO/cGMP pathway in toluene-induced locomotor hyperactivity in female rats. Psychopharmacology 2004, 176:435-439.
10. Chen H.H., Stoker A., Markou A. The glutamatergic compounds sarcosine and N-acetylcysteine ameliorate prepulse inhibition deficits in metabotropic glutamate 5 receptor knockout mice. Psychopharmacology 2010, 209:343-350.
11. Chouaniere D., Wild P., Fontana J.M., Hery M., Fournier M., Baudin V., Subra I., Rousselle D., Toamain J.P., Saurin S., Ardiot M.R. Neurobehavioral disturbances arising from occupational toluene exposure. Am. J. Ind. Med. 2002, 41:77-88.
12. Conti A.C., Lowing J.L., Susick L.L., Bowen S.E. Investigation of calcium-stimulated adenylyl cyclases 1 and 8 on toluene and ethanol neurobehavioral actions. Neurotoxicol. Teratol. 2012, 34:481-488.
13. Cruz S.L., Mirshahi T., Thomas B., Balster R.L., Woodward J.J. Effects of the abused solvent toluene on recombinant N-methyl-d-aspartate and non-N-methyl-d-aspartate receptors expressed in Xenopus oocytes. J. Pharmacol. Exp. Ther. 1998, 286:334-340.
14. Dell C.A., Gust S.W., MacLean S. Global issues in volatile substance misuse. Subst. Use Misuse 2011, 46(Suppl. 1):1-7.
15. Eulenburg V., Armsen W., Betz H., Gomeza J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci. 2005, 30:325-333.
16. Flanagan R.J., Fisher D.S. Volatile substance abuse and crime: data from U.K. press cuttings 1996-2007. Med. Sci. Law 2008, 48:295-306.
17. Flanagan R.J., Ives R.J. Volatile substance abuse. Bull. Narc. 1994, 46:49-78.
18. Garland E.L., Howard M.O. Phenomenology of adolescent inhalant intoxication. Exp. Clin. Psychopharmacol. 2010, 18:498-509.
19. Gordon C.J., Gottipolu R.R., Kenyon E.M., Thomas R., Schladweiler M.C., Mack C.M., Shannahan J.H., Wallenborn J.G., Nyska A., MacPhail R.C., Richards J.E., Devito M., Kodavanti U.P. Aging and susceptibility to toluene in rats: a pharmacokinetic, biomarker, and physiological approach. J. Toxicol. Environ. Health A 2010, 73:301-318.
20. Hancock P.J., Stamford J.A. Stereospecific effects of ketamine on dopamine efflux and uptake in the rat nucleus accumbens. Br. J. Anaesth. 1999, 82:603-608.
21. Herberg L.J., Rose I.C. The effect of MK-801 and other antagonists of NMDA-type glutamate receptors on brain-stimulation reward. Psychopharmacology 1989, 99:87-90.
22. Howard M.O., Bowen S.E., Garland E.L., Perron B.E., Vaughn M.G. Inhalant use and inhalant use disorders in the United States. Addict. Sci. Clin. Pract. 2011, 6:18-31.
23. Huerta-Rivas A., Lopez-Rubalcava C., Sanchez-Serrano S.L., Valdez-Tapia M., Lamas M., Cruz S.L. Toluene impairs learning and memory, has antinociceptive effects, and modifies histone acetylation in the dentate gyrus of adolescent and adult rats. Pharmacol. Biochem. Behav. 2012, 102:48-57.
24. Karasawa J., Hashimoto K., Chaki S. d-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats. Behav. Brain Res. 2008, 186:78-83.
25. Kenny P.J., Chartoff E., Roberto M., Carlezon W.A., Markou A. NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 2009, 34:266-281.
26. Lane H.Y., Lin C.H., Huang Y.J., Liao C.H., Chang Y.C., Tsai G.E. A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and d-serine add-on treatment for schizophrenia. Int. J. Neuropsychopharmacol. 2010, 13:451-460.
27. Lo P.S., Wu C.Y., Sue H.Z., Chen H.H. Acute neurobehavioral effects of toluene: involvement of dopamine and NMDA receptors. Toxicology 2009, 265:34-40.
28. Long K.D., Mastropaolo J., Rosse R.B., Manaye K.F., Deutsch S.I. Modulatory effects of d-serine and sarcosine on NMDA receptor-mediated neurotransmission are apparent after stress in the genetically inbred BALB/c mouse strain. Brain Res. Bull. 2006, 69:626-630.
29. Lopez-Corcuera B., Martinez-Maza R., Nunez E., Roux M., Supplisson S., Aragon C. Differential properties of two stably expressed brain-specific glycine transporters. J. Neurochem. 1998, 71:2211-2219.
30. Lubman D.I., Yucel M., Lawrence A.J. Inhalant abuse among adolescents: neurobiological considerations. Br. J. Pharmacol. 2008, 154:316-326.
31. Manahan-Vaughan D., Wildforster V., Thomsen C. Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter-1 (GlyT1). Eur. J. Neurosci. 2008, 28:1342-1350.
32. Meulenbelt J., de Groot G., Savelkoul T.J. Two cases of acute toluene intoxication. Br. J. Ind. Med. 1990, 47:417-420.
33. Paxinos G., Franklin K. The mouse brain in stereotaxic coordinates 2001, Academic Press, San Diego, CA. 2nd ed.
34. Riegel A.C., French E.D. Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride. Pharmacol. Biochem. Behav. 1999, 62:399-402.
35. Riegel A.C., Ali S.F., French E.D. Toluene-induced locomotor activity is blocked by 6-hydroxydopamine lesions of the nucleus accumbens and the mGluR2/3 agonist LY379268. Neuropsychopharmacology 2003, 28:1440-1447.
36. Saito K., Wada H. Behavioral approaches to toluene intoxication. Environ. Res. 1993, 62:53-62.
37. Shelton K.L. Inhaled toluene vapor as a discriminative stimulus. Behav. Pharmacol. 2007, 18:219-229.
38. Shelton K.L., Slavova-Hernandez G. Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration. Pharmacol. Biochem. Behav. 2009, 92:614-620.
39. Smith K.E., Borden L.A., Hartig P.R., Branchek T., Weinshank R.L. Cloning and expression of a glycine transporter reveal colocalization with NMDA receptors. Neuron 1992, 8:927-935.
40. Stoker A.K., Semenova S., Markou A. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology 2008, 54:1223-1232.
41. Tegeris J.S., Balster R.L. A comparison of the acute behavioral effects of alkylbenzenes using a functional observational battery in mice. Fundam. Appl. Toxicol. 1994, 22:240-250.
42. Win-Shwe T.T., Fujimaki H. Acute administration of toluene affects memory retention in novel object recognition test and memory function-related gene expression in mice. J. Appl. Toxicol. 2012, 32:300-304.
43. Win-Shwe T.T., Mitsushima D., Nakajima D., Ahmed S., Yamamoto S., Tsukahara S., Kakeyama M., Goto S., Fujimaki H. Toluene induces rapid and reversible rise of hippocampal glutamate and taurine neurotransmitter levels in mice. Toxicol. Lett. 2007, 168:75-82.
44. Win-Shwe T.T., Kageyama S., Tsukahara S., Nakajima D., Fujimaki H. Effect of d-cycloserine on spatial learning performance and memory function-related gene expression in mice following toluene exposure. J. UOEH 2010, 32:127-140.
45. Wittwer A.J., Wagner C. Identification of the folate-binding proteins of rat liver mitochondria as dimethylglycine dehydrogenase and sarcosine dehydrogenase. Flavoprotein nature and enzymatic properties of the purified proteins. J. Biol. Chem. 1981, 256:4109-4115.
46. Wood R.W., Colotla V.A. Biphasic changes in mouse motor activity during exposure to toluene. Fundam. Appl. Toxicol. 1990, 14:6-14.
47. Yang F.Y., Lee Y.S., Cherng C.G., Cheng L.Y., Chang W.T., Chuang J.Y., Kao G.S., Yu L. d-cycloserine, sarcosine and d-serine diminish the expression of cocaine-induced conditioned place preference. J. Psychopharmacol. 2010, published online 24 November 2010 as http://dx.doi.org/10.1177/0269881110388333.
48. Yang S.Y., Hong C.J., Huang Y.H., Tsai S.J. The effects of glycine transporter I inhibitor, N-methylglycine (sarcosine), on ketamine-induced alterations in sensorimotor gating and regional brain c-Fos expression in rats. Neurosci. Lett. 2010, 469:127-130.
49. Yavich L., Zvartau E. A comparison of the effects of individual organic solvents and their mixture on brain stimulation reward. Pharmacol. Biochem. Behav. 1994, 48:661-664.
50. Zhang H.X., Hyrc K., Thio L.L. The glycine transport inhibitor sarcosine is an NMDA receptor co-agonist that differs from glycine. J. Physiol. 2009, 587:3207-3220.